• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别糖尿病患者队列中的血糖变异性并评估疾病结局。

Identifying Glycemic Variability in Diabetes Patient Cohorts and Evaluating Disease Outcomes.

作者信息

Nwadiugwu Martin C, Bastola Dhundy R, Haas Christian, Russell Doug

机构信息

Department of Biomedical Informatics, University of Nebraska at Omaha, Omaha, NE 68182, USA.

Department of Information Systems and Quantitative Analysis, University of Nebraska at Omaha, Omaha, NE 68182, USA.

出版信息

J Clin Med. 2021 Apr 2;10(7):1477. doi: 10.3390/jcm10071477.

DOI:10.3390/jcm10071477
PMID:33918347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8038275/
Abstract

Glycemic variability (GV) is an obstacle to effective blood glucose control and an autonomous risk factor for diabetes complications. We, therefore, explored sample data of patients with diabetes mellitus who maintained better amplitude of glycemic fluctuations and compared their disease outcomes with groups having poor control. A retrospective study was conducted using electronic data of patients having hemoglobin A1C (HbA1c) values with five recent time points from Think Whole Person Healthcare (TWPH). The control variability grid analysis (CVGA) plot and coefficient of variability (CV) were used to identify and cluster glycemic fluctuation. We selected important variables using LASSO. Chi-Square, Fisher's exact test, Bonferroni chi-Square adjusted residual analysis, and multivariate Kruskal-Wallis tests were used to evaluate eventual disease outcomes. Patients with very high CV were strongly associated ( < 0.05) with disorders of lipoprotein ( = 0.0014), fluid, electrolyte, and acid-base balance ( = 0.0032), while those with low CV were statistically significant for factors influencing health status such as screening for other disorders ( = 0.0137), long-term (current) drug therapy ( = 0.0019), and screening for malignant neoplasms ( = 0.0072). Reducing glycemic variability may balance alterations in electrolytes and reduce differences in lipid profiles, which may assist in strategies for managing patients with diabetes mellitus.

摘要

血糖变异性(GV)是有效控制血糖的障碍,也是糖尿病并发症的一个独立危险因素。因此,我们探讨了血糖波动幅度较好的糖尿病患者的样本数据,并将他们的疾病结局与控制不佳的组进行了比较。利用来自全人医疗(TWPH)的血红蛋白A1C(HbA1c)值在最近五个时间点的患者电子数据进行了一项回顾性研究。使用控制变异性网格分析(CVGA)图和变异系数(CV)来识别和聚类血糖波动。我们使用LASSO选择重要变量。使用卡方检验、Fisher精确检验、Bonferroni卡方调整残差分析和多变量Kruskal-Wallis检验来评估最终的疾病结局。CV非常高的患者与脂蛋白紊乱(=0.0014)、体液、电解质和酸碱平衡紊乱(=0.0032)密切相关(<0.05),而CV低的患者在影响健康状况的因素方面具有统计学意义,如筛查其他疾病(=0.0137)、长期(当前)药物治疗(=0.0019)和筛查恶性肿瘤(=0.0072)。降低血糖变异性可能平衡电解质变化并减少脂质谱差异,这可能有助于糖尿病患者的管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/6c815be9eb17/jcm-10-01477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/0c9c5a0a12a2/jcm-10-01477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/d57ae8c46a70/jcm-10-01477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/776450268ccc/jcm-10-01477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/6c815be9eb17/jcm-10-01477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/0c9c5a0a12a2/jcm-10-01477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/d57ae8c46a70/jcm-10-01477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/776450268ccc/jcm-10-01477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa14/8038275/6c815be9eb17/jcm-10-01477-g004.jpg

相似文献

1
Identifying Glycemic Variability in Diabetes Patient Cohorts and Evaluating Disease Outcomes.识别糖尿病患者队列中的血糖变异性并评估疾病结局。
J Clin Med. 2021 Apr 2;10(7):1477. doi: 10.3390/jcm10071477.
2
Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.速效胰岛素类似物与常规人胰岛素对比:糖尿病患者血糖控制效果的荟萃分析
Diabetes Ther. 2020 Mar;11(3):573-584. doi: 10.1007/s13300-019-00732-w. Epub 2019 Dec 23.
3
Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy: A Strobe-compliant article.胰岛素治疗的住院 2 型糖尿病患者血糖变异性的影响因素:一篇符合 STROBE 规范的文章。
Medicine (Baltimore). 2017 Sep;96(36):e8021. doi: 10.1097/MD.0000000000008021.
4
A View Beyond HbA1c: Role of Continuous Glucose Monitoring.糖化血红蛋白之外的视角:持续葡萄糖监测的作用
Diabetes Ther. 2019 Jun;10(3):853-863. doi: 10.1007/s13300-019-0619-1. Epub 2019 Apr 29.
5
Patterns of Glycemic Variability During a Diabetes Self-Management Educational Program.糖尿病自我管理教育项目期间的血糖变异性模式
Med Sci (Basel). 2019 Mar 25;7(3):52. doi: 10.3390/medsci7030052.
6
The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.糖化血红蛋白控制良好的2型糖尿病患者血糖变异性与糖尿病周围神经病变的关系
Diabetol Metab Syndr. 2014 Dec 15;6(1):139. doi: 10.1186/1758-5996-6-139. eCollection 2014.
7
To What Extent Is Hb Associated with Glycemic Variability in Patients with Type 1 Diabetes? A Retrospective, Noninterventional Study.1型糖尿病患者中血红蛋白与血糖变异性的关联程度如何?一项回顾性、非干预性研究。
J Clin Med. 2024 Jan 13;13(2):450. doi: 10.3390/jcm13020450.
8
The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus.长期既往血糖控制对2型糖尿病患者执行功能的影响。
Diabetol Int. 2019 Oct 3;11(2):114-120. doi: 10.1007/s13340-019-00411-y. eCollection 2020 Apr.
9
Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.1 型糖尿病的血糖变异性衡量指标及实时连续血糖监测的影响。
Diabetes Technol Ther. 2016 Dec;18(12):806-812. doi: 10.1089/dia.2016.0146.
10
The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait.科威特达斯曼糖尿病研究所2型糖尿病患者的代谢控制状况
Front Endocrinol (Lausanne). 2019 Jun 26;10:412. doi: 10.3389/fendo.2019.00412. eCollection 2019.

引用本文的文献

1
Association of glycemic variability and time in range with lipid profile in type 1 diabetes.血糖变异性和达标时间与 1 型糖尿病患者血脂谱的相关性研究。
Endocrine. 2024 Jan;83(1):69-76. doi: 10.1007/s12020-023-03464-x. Epub 2023 Dec 5.
2
Distributed Assessment of Virtual Insulin-Pump Settings Using SmartCGMS and DMMS.R for Diabetes Treatment.使用智能 CGMS 和 DMMS.R 分布式评估虚拟胰岛素泵设置用于糖尿病治疗。
Sensors (Basel). 2022 Dec 2;22(23):9445. doi: 10.3390/s22239445.
3
In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.

本文引用的文献

1
Inflammatory Activities in Type 2 Diabetes Patients With Co-morbid Angiopathies and Exploring Beneficial Interventions: A Systematic Review.2 型糖尿病合并血管病变患者的炎症活动及有益干预措施的探索:系统评价。
Front Public Health. 2021 Jan 25;8:600427. doi: 10.3389/fpubh.2020.600427. eCollection 2020.
2
Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status.老年人多病共存:多药治疗与社会经济地位的考察。
Front Public Health. 2021 Jan 18;8:582234. doi: 10.3389/fpubh.2020.582234. eCollection 2020.
3
Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches.
新型延长佩戴、抗扭结胰岛素输注套件与商用对照在两周佩戴时间内的炎症组织反应的体内研究。
J Diabetes Sci Technol. 2023 Nov;17(6):1563-1572. doi: 10.1177/19322968221093362. Epub 2022 May 9.
4
Self-Monitoring of Blood Glucose for Patients With Type 2 Diabetes in Primary Care: A Single-Centre, 10-Year Retrospective Analysis.基层医疗中2型糖尿病患者的血糖自我监测:一项单中心10年回顾性分析
Cureus. 2021 Jun 11;13(6):e15597. doi: 10.7759/cureus.15597. eCollection 2021 Jun.
老年人的衰弱与多重用药风险:促进和预防方法
J Aging Res. 2020 Jun 29;2020:6759521. doi: 10.1155/2020/6759521. eCollection 2020.
4
Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes: A nationwide population-based study.长期血糖变异性对无糖尿病受试者发生心血管疾病及死亡的影响:一项基于全国人群的研究。
Medicine (Baltimore). 2019 Jul;98(29):e16317. doi: 10.1097/MD.0000000000016317.
5
Exploring the use of machine learning for risk adjustment: A comparison of standard and penalized linear regression models in predicting health care costs in older adults.探索机器学习在风险调整中的应用:标准线性回归和惩罚线性回归模型在预测老年人群医疗费用中的比较。
PLoS One. 2019 Mar 6;14(3):e0213258. doi: 10.1371/journal.pone.0213258. eCollection 2019.
6
Glucotypes reveal new patterns of glucose dysregulation.糖谱揭示了葡萄糖失调的新模式。
PLoS Biol. 2018 Jul 24;16(7):e2005143. doi: 10.1371/journal.pbio.2005143. eCollection 2018 Jul.
7
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2017 年全球糖尿病患病率估计数和 2045 年预测值。
Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.
8
Fisher's exact approach for post hoc analysis of a chi-squared test.用于卡方检验事后分析的费舍尔精确法。
PLoS One. 2017 Dec 20;12(12):e0188709. doi: 10.1371/journal.pone.0188709. eCollection 2017.
9
Evaluation of Electrolytes Imbalance and Dyslipidemia in Diabetic Patients.糖尿病患者电解质失衡和血脂异常的评估
Med Sci (Basel). 2016 Apr 1;4(2):7. doi: 10.3390/medsci4020007.
10
Assessment of Interday Glucose Variability in Type 2 Diabetes.2型糖尿病日间血糖变异性评估
Diabetes Technol Ther. 2017 Aug;19(8):443-445. doi: 10.1089/dia.2017.0255.